Daniel Wei Lin MD

PubMed

• Comparison of Real-World Outcomes between Patients with BRCA1/2-Positive and Homologous Recombination Repair-Negative Metastatic Castration-Sensitive Prostate Cancer.
  Mehmet A Bilen, Sabree Burbage, Carmine Rossi, Ibrahim Khilfeh, Lilian Diaz
  Advances in Therapy. 2025-06-17
• Patterns of intra- and inter-tumor phenotypic heterogeneity in lethal prostate cancer.
  Martine P Roudier, Roman Gulati, Erolcan Sayar, Radhika A Patel, Micah Tratt
  The Journal of Clinical Investigation. 2025-06-10
• Hiding in the kidney: a series of 13 lymphoid proliferations clinically mimicking renal carcinoma.
  Jihoon William Lee, Marie E Perrone, Daniel E Sabath, Daniel W Lin, George R Schade
  Virchows Archiv. 2025-06-09

Journal Articles

• Re: Effects of short-term finasteride on apoptotic factors and androgen receptors in prostate cancer cells.  
  Lin DW, Journal of Urology
• Treatment of Metastatic Prostate Cancer – How Urologists should Sequence Available Agents.  
  Mostaghel EA and Lin DW, AUA Update Series
• Is Pre-diagnosis PSA Velocity Predictive of the Risk of Death from Prostate Cancer Following Radical Prostatectomy?  
  Lin DW and Lange PH, Nature Clinical Practice Urology 1: 66
• Re: Prostate-specific Antigen Velocity in Men with Total Prostate-Specific Antigen Levels Less Than 4ng/ml.  
  Lin DW, Journal of Urology 178: 2352-3
• Re: Prostate-specific antigen velocity and prostate cancer gleason grade and stage.  
  Lin DW, Urologic Oncology 25: 529
• Re: Active surveillance for prostate cancers detected in three subsequent rounds of a screening trial: characteristics, PSA doubling times, and outcome.  
  Lin DW, Urologic Oncology 25: 527-8
• Re: EPCA-2: A highly specific serum marker for prostate cancer.  
  Lin DW, Urologic Oncology 25: 528
• Re:Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional pilot study.  
  Lin DW, Urologic Oncology 25: 528-9
• Re: Marked Gene Transcript Level Alterations Occur Early During Radical Prostatectomy.  
  Lin DW, Eur Urology 53: 345-6
• Re: Role of repeated biopsy of the prostate in predicting disease progression in patients with prostate cancer on active surveillance.  
  Lin DW, Urologic Oncology 26: 680-1
• Re: Preoperative prediction of unifocal, unilateral, margin-negative, and small volume prostate cancer.  
  Lin DW, Urologic Oncology 26: 681-2
• Re: Prostate cancer-specific survival following salvage radiotherapy vs observation in men with biochemical recurrence after prostatectomy.  
  Lin DW, Urologic Oncology 26: 682-3
• Testicular Cancer Guidelines.  
  Motzer RJ, Agarwal N, Beard C, Bhayani S, Bolger GB, Buyyounouski MK, Carducci MA, Chang SS, Choueiri TK, Gupta S, Hancock SL, Hudes GR, Jonasch E, Kuzel TM, Lau C, Le..., J Natl Compr Canc Netw 10:502-35
• Re: Adjuvant radiotherapy for patients with locally advanced prostate cancer – a new standard?  
  Lin DW, Urologic Oncology
• Re: Primary Retroperitoneal Lymph Node Dissection in Patients With Clinical Stage IS Testis Cancer.  
  Lin DW, Journal of Urology 182:2720
• Prostate cancer risk stratification by genotype and PSA.  
  Wright JL and Lin DW, Nature Reviews Urology 6:641-2
• Re: Mortality results from a randomized prostate-cancer screening trial: Andriole GL, Crawford ED, Grubb RL III, et al.  
  Lin DW, Urologic Oncology 27: 688-9
• Re: Improved sensitivity for detecting micrometastases in pelvic lymph nodes by real-time reverse transcriptase polymerase chain reaction (RT-PCR) compared with conven...  
  Lin DW, Urologic Oncology 27: 689-90
• Re: Selective inhibition of CYP17 with abiraterone acetate is highly active in the treatment of castration-resistant prostate cancer: Attard G, Reid AH, A'Hern R, et al.  
  Lin DW, Urologic Oncology 27: 690-1
• Re: Can contemporary transrectal prostate biopsy accurately select candidates for hemi-ablative focal therapy of prostate cancer?: Tareen B, Godoy G, Sankin A, et al.  
  Lin DW, Urologic Oncology 27: 691
• Re: Phase 1 trial of high-dose exogenous testosterone in patients with castration-resistant metastatic prostate cancer: Morris MJ, Huang D, Kelly WK, et al.  
  Lin DW, Urologic Oncology 27: 692
• Value of Urethral Wash after Radical Cystectomy.  
  Lin DW, Herr HW, Dalbagni G, Journal of Urology 165 (5 suppl): 715A
• Phenotypic Heterogeneity in Disseminated Prostate Cancer Tumor Cells: Implications in Epithelial to Mesenchymal Transition.  
  Koreckij TD, Morgan TM, Lange PH, Coleman I, Coleman R, Ellis WJ, Lin DW, Montgomery B, Lakely B, Morrissey C, and Vessella RL, Journal of Urology 181 (4 suppl): 2086A
• Tumor lysis syndrome in a patient with metastatic, androgen independent prostate cancer.  
  Wright JL, Lin DW, Dewan P, and Montgomery RB, International Journal of Urology 12: 1012-3
• Transition Zone PSA Density: Lack of Utility in Prediction of Prostatic Carcinoma.  
  Lin DW, Gold MH, Ransom S, Ellis WJ, Brawer MK, Journal of Urology 160: 77-82
• Join now to see all

Books/Book Chapters

• Practical Cases in Urology. 
  Chapter: Current Management of Testis Cancer 
  Lin DW and Lange PHEditors: AJ Wein.American Urological Association, Inc
• Prostatic Diseases. 
  Chapter: Epidemiology and Natural History of Prostate Cancer 
  Page 345 - 356Lin DW and Lange PHEditors: H Lepor.W.B.Saunders Co
• Prostate Cancer: Principles and Practice. 
  Chapter: Tumor Markers in Prostate Cancer 
  Page 305 - 312Lin DW, Vessella RL, and Lange PHEditors: P Carroll and A D’Amico.W.B. Saunders Co
• Management of Prostate Cancer: Advances and Controversies. 
  Chapter: Anatomical Radical Prostatectomy in the Management of Localized Prostate Cancer 
  Page 55 - 60Lin DW, Eastham JA, and Scardino PTEditors: KB Cummings.Marcel Dekker, Inc
• Mechanisms of Metastasis. 
  Chapter: Detection, Isolation, and Study of Disseminated Prostate Cancer Cells in the Peripheral Blood and Bone Marrow 
  Lin DW, Pfitzenmaier J, Ellis WJ, Lange PH, and Vessella RLEditors: C Rinker-Schaeffer.Humana Press, Inc
• Prostate Cancer: Principles and Practice. 
  Chapter: PSA: Practical Applications and Future Prospects 
  Lin DW and Brawer MKEditors: R Kirby, A Partin, M Feneley, JK Parsons.Martin Dunitz Ltd
• Intermittent Androgen Deprivation: Clinical Experience and Practical Applications. 
  Page 167 - 169Wright JL, Higano CS, and Lin DWEditors: J Smith.Saunders Inc
• Role of Post-Chemotherapy Surgery in Germ Cell Tumors. 
  Page 199 - 217Sim HG, Lange PH, and Lin DWEditors: J Sheinfeld.Saunders Inc
• Complications of Urologic Surgery: Prevention and Management. 
  Chapter: Toxicities of Chemotherapy for Genitourinary Malignancies 
  Page 117 - 124Montgomery RB and Lin DWEditors: SS Taneja.Elsevier Inc
• Comprehensive Textbook of Genitourinary Oncology. 
  Chapter: Role of Post-Chemotherapy Surgery in Germ Cell Tumors 
  Sim HG and Lin DWEditors: N Vogelzang, P Scardino.
• Join now to see all

Abstracts/Posters

• Prostate cancer ≤ 2 cells from the surgical margin predicts biochemical recurrence.
  Izard JP, True LD, May PC, Ellis WJ, Lange PH, Lin DW, and Wright JL, Journal of Urology 187 (4 suppl): 1641A
• Transurethral Needle Ablation of the Prostate for Treatment of Benign Prostatic Hyperplasia: the University of Washington Experience.
  Lin DW, Ellis WJ, American Urological Association
• Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) in Bone Marrow Aspirates Following Radical Prostatectomy with Extended Follow-up.
  Lin DW, Ellis WJ, Arfman EW, Sohn A, Corey E, Lange PH, Vessella RL, American Urological Association
• Salvage Cystoprostatectomy for Treatment of Recurrent Prostate Cancer After Radiation Treatment.
  Lin DW, Ellis WJ, Lange PH, American Urological Association
• Primary Penile Lymphoma Treated With Surgical Excision.
  Lin DW, Krieger JN, Northwest Urological Society, Seattle, WA
• Transurethral Needle Ablation of the Prostate for Treatment of Benign Prostatic Hyperplasia: the University of Washington Experience.
  Lin DW, Ellis WJ, Northwest Urological Society, Seattle, WA
• Efficacy of Acucise Incision on Uretero-Enteral Strictures.
  Lin DW, Bush WH, Mayo ME, Northwest Urologic Association, Portland, OR
• The NCI Early Detection Research Network (EDRN) Urinary PCA3 Validation Trial.
  Wei J, Sanda M, Thompson I, Partin A, Feng Z, Sokoll L, Groskopf J, Brown E, Lotan Y, Kibel A, Busby E, Bidair M, Lin D, Taneja S, and Viterbo R, Journal of Urology 187 (4 suppl): 2206A
• Correlation of urine PCA3 score and TMPRS2:ERG score with clinically significant tumor volume in radical prostatectomy specimens: Interim results from a multi-center p...
  Davis J, Troncoso P, Meyer S, Day J, Groskopf J, Aubin S, Rodriguez Y, Lin DW, Vakar-Lopez F, Magi-Galluzzi C, and Bergland R, Journal of Urology 187 (4 suppl): 2112A
• A randomized pilot study of a reduced-calorie versus standard diet in overweight men with newly diagnosed prostate cancer.
  Wright JL, Plymate S, D’Oria-Cameron A, Bain C, Haugk K, Xiao L, Lin DW, Stanford JL, and McTeirnan A, Journal of Urology 187 (4 suppl): 1823A
• Serum Percent Free Prostate-Specific Antigen (f-PSA) in Metastatic Prostate Cancer.
  Lin DW, Noteboom JL, Ellis WJ, Blumenstein B, Lange PH, Vessella RL, Western Section American Urological Association
• Serum glucose is associated with biochemical recurrence in men without diabetes treated for localized prostate cancer.
  Wright JL, Gore JL, Porter MP, Lin DW, Hu E, and Zeliadt, Journal of Urology 187 (4 suppl): 177A
• of a circulating Microvesicle-based Assay in At-Risk Patients for the Detection of Prostate Cancer.
  Kibel A, Andriole G, Lin DW, Vessella RL, Stratton S, Sokoloff M, Spetzler D, and Kuslich C, Journal of Urology 185 (4 suppl): 1924A
• Decisional Conflict Varies by Institution for Men Making Treatment Decisions for Localized Prostate Cancer.
  Berry D, Hong F, Halpenny B, Wolpin S, Lober W, Russell K, Ellis WJ, Davison J, Barsevick A, Yang C, Lin DW, and Bennett G, Journal of Urology 185 (4 suppl): 1001A
• A Randomized Pilot Study to Assess Anxiety Related to Distributing a Prostate Cancer Treatment Decision Aid Prior to Biopsy.
  Zeliadt S, Bonner L, Trivedi R, Kimmie C, Hannon P, Vu T, Zipperer C, Porter M, and Lin DW, Journal of Urology 185 (4 suppl): 627A
• Positive Surgical Margins at Radical Prostatectomy: National Averages Within PSA and Gleason Strata.
  Salazar M, Chatterjee S, Lin DW, and Wright JL, Journal of Urology 185 (4 suppl): 154A
• The Cost-Effectiveness of the Double Benefit of 5-Alpha-Reductase Inhibitor (5ARI) Chemoprevention on Both Undisclosed Genitourinary Symptoms and Prostate Cancer.
  Westerman S, Zeliadt S, Gore JL, and Lin DW, Journal of Urology 185 (4 suppl): 71A
• AMACR Polymorphisms, Dietary Intake and Prostate Cancer Risk.
  Wright JL, Neuhouser ML, Lin DW, Kwon EM, Feng Z, Ostrander EA, and Stanford JL, Journal of Urology 183 (4 suppl): 2055A
• The Effect of Demographic and Clinical Factors on the Relationship Between BMI and PSA Levels.
  Wright JL, Lin DW, and Stanford JL, Journal of Urology 183 (4 suppl): 2059A
• Diethylstilbestrol and docetaxel: a phase II study in patients with metastatic androgen independent prostate cancer.
  Montgomery B, Lin DW, Ryan C, Garzotto M, and Beer TM, Multidisciplinary Prostate Cancer Symposium, Orlando, FL
• Progression and treatment in a multi-institutional, prospective active surveillance study: Results from Canary Prostate Active Surveillance Study (PASS).
  Lin DW, Newcomb L, Ellis W, Gleave M, Thompson I, Brooks J, Nelson P, Sanda M, Lance R, Wei J, Feng Z, Carroll P, and Canary/EDRN Investigators, American Urological Association 2012 Annual Meeting, Atlanta, GA
• Toremifene Demonstrates Reduction in Fracture risk in Men Less Than 80 Years of Age on Androgen Deprivation Therapy.
  Lin DW, Marks LS, Morton RA, Steiner MS, and Brawer MK, Western Section American Urological Association, Hawaii
• The Effect of Toremifene on PSA Progression-Free Survival in Castrate Men with Detectable Baseline PSA Levels.
  Lin DW, Barnett G, Brawer MK, Smith M, Morton R, Steiner M, and Yu E, Northwest Urological Society Scientific Program, Bellevue, WA
• Global gene expression changes in human prostate tissue in response to dietary intervention.
  Lin DW, Neuhouser ML, Schenk JM, Coleman IM, Hawley S, Gifford D, Hung H, Knudsen BS, Nelson PS, and Kristal AR, Western Section American Urological Association, Maui, HI
• Quality of Life in Young Men after Radical Prostatectomy: Results from the CAPSURE Registry.
  Wright JL, Lin DW, Cowan JE, DuChane J, Carroll PR, and Litwin MS, American Society of Clinical Oncology, 2006 Annual Meeting, Atlanta, GA
• Join now to see all

Lectures

• Beyond PSA: Utility of Novel Tumor Markers in the Setting of Elevated PSA. 
  American Urological Association 2008 Annual Meeting, Orlando, FL
• Adjuvant Chemohormonal Therapy in High Risk Prostate Cancer: a Point-Counterpoint Debate. 
  Northwest Urological Society Annual Meeting, Spokane, WA
• Progress and Promise in Prostate Cancer Research. 
  VA R&D Research Colloquium, Seattle, WA
• Everything You Want To Know About Prostate Cancer in 2007. 
  American Association of Pediatric Ophthalmology and Strabismus Annual Meeting, Seattle, WA
• Screening and Diagnosis of Prostate Cancer. 
  Providence Saint Joseph Medical Center Grand Rounds, Burbank, CA
• Clinical Scenarios and Treatment Strategies for Advanced Prostate Cancer in Younger Men. 
  Multiple locations, 2006
• Prostate Anatomy and Evaluation of Lower Urinary Tract Symptoms. 
  Men’s Health Update CME Course, Seattle, WA
• Prostate Carcinogenesis. 
  Men’s Health Update CME Course, Seattle, WA
• Diagnosis and Management of Clinically Localized Prostate Cancer 2007. 
  Seattle Cancer Care Alliance Outreach Symposium, Great Falls, MT
• Management of High Risk Prostate Cancer. 
  Urology Research Forum, Charles University, Prague, Czechoslovakia
• Prostate Cancer Update 2006. 
  Evergreen Hospital Grand Rounds, Kirkland, WA
• Non-Muscle Invasive Bladder Cancer: AUA Management Guidelines. 
  American Urological Association 2008 Annual Meeting CME Course Faculty, Orlando, FL
• Adjuvant Treatment Strategies for High-Risk Post-Prostatectomy Prostate Cancer: Emerging Data and New Directions. 
  Multiple locations, 2007
• Risk Stratification, Mechanisms of Recurrence, and Adjuvant Treatment Strategies for High-Risk Post-Prostatectomy Prostate Cancer. 
  Scott Department of Urology Grand Rounds, Baylor University School of Medicine, Houston, TX
• Prostate Cancer Screening and Rationale For/Against Early Detection of Localized Prostate Cancer. 
  Annual Advances in Family Practice and Primary Care, Seattle, WA
• Prostate Cancer Screening and Evaluation and Treatment of Newly Diagnosed Prostate Cancer. 
  Puget Sound Health Care System Prostate Cancer Awareness Month Symposium, Seattle, WA
• The Effects of Sulforaphane on Normal Human Prostate Cells: Mechanisms of Cancer Prevention and Rationale for Clinical Trial. 
  Pacific NW Prostate Cancer SPORE External Advisory Board Symposium, Seattle, WA
• Beyond PSA: Utility of Novel Prostate Cancer Markers in Advanced Disease. 
  Moffitt Cancer Center Advanced Prostate Cancer Collaboration, Tampa, FL
• Progress and Promise in Prostate Cancer. 
  Albany VA Grand Rounds, Albany, NY
• The Role of Peri-Operative Chemotherapy in High-Risk Prostate Cancer: PUNCH and VA Surgical Trials. 
  3rd Annual John R. Murren Oncology Symposium, Las Vegas, NV
• Disseminated Tumor Cells: Clinical Applications, Prognostic Significance, and Future Directions in Prostate Cancer Patients. 
  American Society of Clinical Oncology 2005 Annual Meeting: Invited abstract discussant, Orlando, FL
• Screening, Detection, and Staging of Prostate Cancer. 
  5th Annual North Puget Sound Oncology Symposium, Mount Vernon, WA
• Detection and Isolation of PSA Positive Epithelial Cells by Enrichment: Comparison to Standard RT-PCR, Clinical Relevance, and Initial Characterization in Prostate Can... 
  InterProstate SPORE Meeting, Chicago, IL
• Prostate Cancer Screening, Detection, and Treatment. 
  Auburn Regional Medical Center Grand Rounds, Auburn, WA
• Recent Advances in the Treatment of Hormone Refractory Prostate Cancer. 
  80th Annual Western Section American Urological Association Meeting, San Diego, CA
• Join now to see all